Abstract. Twenty-seven patients with active acromegaly despite previous treatment by surgery and/or radiotherapy received bromocriptine in a dose of 10\p=n-\20mg daily for a period of 6\p=n-\9months. The results of chronic bromocriptine treatment were evaluated by measurement of plasma growth hormone (GH) levels during the day and by subjective and objective criteria of clinical activity. The results of chronic bromocriptine treatment were also compared with four biochemical criteria obtained before treatment e.g. basal plasma prolactin (Prl) levels and the plasma GH response to oral administration of 2.5 mg bromocriptine respectively iv administration of 200 \ s=u\ g TRH and 500 \ s=u\ g somatostatin. The main observations may be summarized as follows: 1) The mean pre-treatment GH levels during the day ranged from 6\p=n-\207mU/l. Hyperprolactinaemia was present in 6 patients. 2) During bromocriptine treatment mean plasma GH levels decreased to less than 50% in 11 patients (GH responders) whereas in 19 patients changes of mean plasma GH and of subjective criteria of clinical activity were concordant. 3) Glucose tolerance improved significantly (P < 0.01) in 10 GH-responders and the urinary hydroxyproline/creatinine ratio decreased significantly (P < 0.05) in 8 GH-responders. 4) Five out of 6 patients with hyperprolactinaemia belonged to the group of GHresponders. 5) A single dose of 2.5 mg bromocriptine induced a more than 50% decrease of plasma GH in 8 of 11 GH-responders and in 5 of 16 GH non-responders. 6) The iv injection of 200 \ s=u\ g TRH was followed by a rise of plasma GH of more than 100% in 9 of 11 GHresponders and in 6 of 16 non-responders. 7) Responsiveness to both a single dose of bromocriptine and TRH was found in 8 of 11 GH-responders and in 3 of 16 GH non-responders. 
pre-treatment GH levels during the day ranged from 6\p=n-\207mU/l. Hyperprolactinaemia was present in 6 patients. 2) During bromocriptine treatment mean plasma GH levels decreased to less than 50% in 11 patients (GH responders) whereas in 19 patients changes of mean plasma GH and of subjective criteria of clinical activity were concordant. 3) Glucose tolerance improved significantly (P < 0.01) in 10 GH-responders and the urinary hydroxyproline/creatinine ratio decreased significantly (P < 0.05) in 8 GH-responders. 4) Five out of 6 patients with hyperprolactinaemia belonged to the group of GHresponders. 5) A single dose of 2.5 mg bromocriptine induced a more than 50% decrease of plasma GH in 8 of 11 GH-responders and in 5 of 16 GH non-responders. 6) The iv injection of 200 \ s=u\ g TRH was followed by a rise of plasma GH of more than 100% in 9 of 11 GHresponders and in 6 of 16 non-responders. 7) Responsiveness to both a single dose of bromocriptine and TRH was found in 8 of 11 GH-responders and in 3 of 16 GH non-responders. In some studies results have been disappointing (Summers et al. 1975; Dunn et al. 1977; Cassar et al. 1977; Roelfsema et al. 1979; Lindholm et (Belforte et al. 1977; Schwinnetal. 1977; Roelfsema et al. 1979 ). These patients are also often characterized by a rise of the plasma GH level after administration of TRH (Liuzzi et al. 1974; Schwinn et al. 1977; Roelfsema et al. 1979 ), a more than 50% decrease of the plasma GH level during somatostatin infusion ) and ele¬ vated basal prolactin levels (Lamberts et al. 1982) . No (patient No. 3, 6, 7, 15, 16, 17, 20, 23 Fig. 2 (r = 0.33, n.s.) . In all patients except one a decrease was found. The mean decrease in the GH-responder group was 3 mm, in the GH non-responder group 1.8 mm.
The results of the plasma GH-response to the administration of a single dose of 2.5 mg bromo¬ criptine, 200 µg TRH and 500 µg somatostatin, the basal plasma Prl level and the combination of the responses to TRH and bromocriptine are shown in Table 3 Correlation between the individual GH response to chronic bromocriptine treatment (horizontal axis) and the change of the mean circumference of the fourth and fifth finger of both hands (vertical axis). (Lamberts et al. 1982 (Lamberts et al. , 1983 although this has not been found by others (Moriondo et al. 1980; Nieuwenhuijzen Krusemanetal. 1983 ).
The increased Prl levels in 6 of out 27 pretreated acromegalie patients were accompanied by responsiveness to TRH and bromocriptine in the acute test in all of them which is in accordance with the reported studies by Lamberts et al. (1979 Lamberts et al. ( , 1982 Lamberts et al. ( , 1983 
